Monday, May 2, 2016
UF Cancer expert steers talk away from chemo
University of Florida Department of Neurosurgery researcher Brent Reynolds told a full-house audience Thursday at the Institute for Human and Machine Cognition Evening Lecture that tens of thousands of dollars spent on conventional chemotherapy treatments in some cases may be of little value.
"The contribution of chemotherapy to cancer outcomes may be small," said Reynolds, who has studied pediatric and adult brain cancer.
Reynolds discovered the existence of tissue-repairing stem cells in the human brain for his doctoral thesis in 1992 — throwing aside 100-year-old dogma they did not exist- and co-founded the first neural stem cell company, NeuroSpheres, Inc.
He has most recently been studying "low toxicity therapeutics" at his UF lab since 2008 like Epidiferphane or EDP, which is composed of several natural ingredients including broccoli powder and curcumin. The EDP is used along with multi-layered approaches including varied levels of standard chemotherapy to treat cancerous tumors.
To date, his work has used animal subjects but human tests are on the horizon, he indicated.
Reynolds, 54, who has published at least 70 research papers and holds 18 U.S. patents, has labeled his approach to cancer treatment "Cancerna", a patented regimen using EDP along with a type of ketogenic diet with 60 percent fat, 20 percent carbs and 20 percent protein, often along with conventional chemotherapy.
Additionally, the "Cancerna" regimen may allow lessening the amount of standard chemotherapy drug or giving the patient a "drug holiday," Reynolds indicated.
Reynolds said the natural methods are safe and help alleviate the effects of chemotherapy on red and white blood cells, which could cause anemia and loss of feeling or hypersensitivity in the extremities.